Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Class I Recall for Contaminated Anesthetic Spray
01/24/2024
A single lot of over-the-counter Americaine 20% Benzocaine Topical Anesthetic Spray is under a Class I recall after a sample from the lot revealed a low level of benzene from the propellant that sprays the product out of the can. Benzene is...
A single lot of over-the-counter Americaine 20% Benzocaine Topical Anesthetic Spray is under a Class I recall after a sample from the lot revealed a low level of benzene from the propellant that sprays the product out of the can. Benzene is...
A single lot of over-the-counter...
01/24/2024
Pharmacy Learning Network
News
Injections Recalled for Possible Glass Particulate Matter
01/24/2024
The potential for the presence of glass particulate matter in the products has prompted Hospira Inc., a Pfizer company, to recall 3 lots containing sodium bicarbonate injections and atropine sulfate injections.
The potential for the presence of glass particulate matter in the products has prompted Hospira Inc., a Pfizer company, to recall 3 lots containing sodium bicarbonate injections and atropine sulfate injections.
The potential for the presence...
01/24/2024
Pharmacy Learning Network
News
US Senators Seek to Improve Drug Access
01/22/2024
“Pharmaceutical companies that develop a drug and have a patent will go to long lengths to keep generic off the market for a longer period of time,” Senator Chuck Grassley (R-Iowa) said in a report.
“Pharmaceutical companies that develop a drug and have a patent will go to long lengths to keep generic off the market for a longer period of time,” Senator Chuck Grassley (R-Iowa) said in a report.
“Pharmaceutical companies that...
01/22/2024
Pharmacy Learning Network

Advertisement

News
Pediatric Hospitalizations Higher for RSV than Omicron or Influenza
01/19/2024
Rates of hospitalization were higher for children with respiratory syncytial virus (RSV) than with Omicron or influenza, according to results from a retrospective cohort study published online ahead of print in JAMA Pediatrics.
Rates of hospitalization were higher for children with respiratory syncytial virus (RSV) than with Omicron or influenza, according to results from a retrospective cohort study published online ahead of print in JAMA Pediatrics.
Rates of hospitalization were...
01/19/2024
Pharmacy Learning Network
News
Immunosuppressant Recalled
01/18/2024
Dr Reddy’s Laboratories Inc. is recalling 8280 bottles of 1-mg tacrolimus capsules. According to the January 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, a 0.5-mg tacrolimus capsule was discovered in a bottle.
Dr Reddy’s Laboratories Inc. is recalling 8280 bottles of 1-mg tacrolimus capsules. According to the January 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, a 0.5-mg tacrolimus capsule was discovered in a bottle.
Dr Reddy’s Laboratories Inc. is...
01/18/2024
Pharmacy Learning Network
News
FDA Approves Vaporized Hydrogen Peroxide as Ethylene Oxide Alternative for Medical Device Sterilization
01/18/2024
The FDA now recognizes vaporized hydrogen peroxide (VHP) as an established method of sterilization for medical devices, promoting the development of alternatives to ethylene oxide (EtO) and aiming to support a resilient supply chain for...
The FDA now recognizes vaporized hydrogen peroxide (VHP) as an established method of sterilization for medical devices, promoting the development of alternatives to ethylene oxide (EtO) and aiming to support a resilient supply chain for...
The FDA now recognizes vaporized...
01/18/2024
Pharmacy Learning Network

Advertisement

News
Antihistamine Recalled for Impurity
01/18/2024
Lupin Pharmaceuticals Inc. is recalling more than 32,000 bottles of 100- and 500-count desloratadine tablets. According to the January 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, an N-nitroso desloratadine impurity was...
Lupin Pharmaceuticals Inc. is recalling more than 32,000 bottles of 100- and 500-count desloratadine tablets. According to the January 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, an N-nitroso desloratadine impurity was...
Lupin Pharmaceuticals Inc. is...
01/18/2024
Pharmacy Learning Network
News
Mobile Opioid Treatment Units Enhance Methadone Availability in Rural Areas
01/18/2024
Mobile opioid treatment program units increase access to methadone for opioid use disorder and are the most impactful in rural areas, according to a study published in Health Services Research.
Mobile opioid treatment program units increase access to methadone for opioid use disorder and are the most impactful in rural areas, according to a study published in Health Services Research.
Mobile opioid treatment program...
01/18/2024
Pharmacy Learning Network
News
Physicians Concerned Weight Loss Drugs May Perpetuate Inequities
01/18/2024
Some physicians are concerned that high demand and prices for high-profile obesity drugs are keeping them out of reach for many who need them, according to a recent Reuters report.
Some physicians are concerned that high demand and prices for high-profile obesity drugs are keeping them out of reach for many who need them, according to a recent Reuters report.
Some physicians are concerned...
01/18/2024
Pharmacy Learning Network

Advertisement

News
Complex Dynamics of the Respiratory Syncytial Virus (RSV) Surge
01/18/2024
Nonviral factors may have also contributed to the surge, including changes in population immunity due to altered RSV dynamics resulting from interventions during the COVID-19 pandemic.
Nonviral factors may have also contributed to the surge, including changes in population immunity due to altered RSV dynamics resulting from interventions during the COVID-19 pandemic.
Nonviral factors may have also...
01/18/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use